Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity
1996
Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer – report on 3-year tumour control and normal tissue toxicity
2000
Nasopharyngeal carcinoma
2005 Standout
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Randomized phase trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-09
1995
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
Adjuvant radiation therapy after surgical resection of solitary brain metastasis: Association with pattern of failure and survival
1987
Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
2007
Inflammatory breast cancer: a review.
1992
The hazard of accelerated tumor clonogen repopulation during radiotherapy
1988 Standout
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
2002 Standout
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
1997
Heating the patient: a promising approach?
2002 Standout
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
1997 Standout
Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases
1995
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas
2003
The cellular and molecular basis of hyperthermia
2002 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Effect of Changing Weekly Dose on Accelerated Repopulation during Fractionated Irradiation of Mouse Tongue Mucosa
1995
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study
1993
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Significance of overall treatment time for the development of radiation-induced intestinal complications. An experimental study in the rat
1994
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
1996 Standout
Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study.
1989
Prophylactic Gastrostomy Tubes in Patients Undergoing Intensive Irradiation for Cancer of the Head and Neck
1998
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
2006
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
Influence of fraction size, total dose, and overall time on local control of T1–T2 glottic carcinoma
1997
Nasopharyngeal carcinoma
2015 Standout
Practice parameters for the management of single brain metastasis
2000
Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma
2001
Continuous, hyperfractionated, accelerated radiotherapy (CHART)
1989
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.
1997
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Resection for solitary brain metastasis
1992
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
2005 Standout
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
2005
Head and Neck Cancer
1993 Standout
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial
2002
A morphometric study of the vascularity of oral squamous cell carcinomas and its relation to outcome of radiation therapy
1989
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
High-dose reirradiation of head and neck cancer with curative intent
1994
Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
1991
Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients
1994
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
Treatment of stage I nasopharyngeal carcinoma: Analysis of the patterns of relapse and the results of withholding elective neck irradiation
1989
Altered fractionation in the treatment of head and neck cancer
1999
Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer
1997
Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial
1993
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
2000
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
1997 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
1996 Standout
Erythropoietin increases hemoglobin in cancer patients during radiation therapy
1993
Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck
1992
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Repopulation response of mouse oral mucosa during unconventional radiotherapy protocols
1995
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck
1997
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years’ experience at Long Beach Memorial
2000
Head and Neck Cancer
2001 Standout
A new approach to dose escalation in non–small-cell lung cancer
2001
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma
1998
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles
1999 Standout
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
1998 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.
1996 Standout
T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated With Radiation Therapy
2001
Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survival
1986
Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model
1988 StandoutScience
Management of brain metastases
2016
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
1998
Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
1996
Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy
1980
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results
1989
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer
1996 Standout
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma
1998
Works of C.C. Wang being referenced
Re-irradiation of laryngeal carcinoma—Techniques and results
1993
Does prolonged treatment course adversely affect local control of carcinoma of the larynx?
1994
Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes
1988
Photon irradiation of unresectable carcinomas of salivary glands
1991
Local control of T3 carcinomas after accelerated fractionation: A look at the “Gap”
1996
Treatment of Malignant Tumors of the Nasopharynx
1980
Twice-a-day radiation therapy for supraglottic carcinoma
1986
Management of solitary metastasis to the brain: The role of elective brain irradiation following complete surgical resection
1980
Management of inflammatory carcinoma of the breast
1978
Physical considerations in the treatment of advanced carcinomas of the larynx and pyriform sinuses using 10 MV X rays
1980
Inflammatory carcinoma of the breast
1964
Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancer
1984